Allomatrix
Device Bone Substitutes
PDI 00840420133496
General payments
$202,415
Research payments
$0
Through program year 2025, $202,415 in general payments and $0 in research payments were reported against Allomatrix (Bone Substitutes).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $13,250 | 332 |
| 2024 | General | $15,921 | 267 |
| 2023 | General | $27,624 | 345 |
| 2022 | General | $124,340 | 403 |
| 2021 | General | $21,279 | 238 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,585 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.